Bloomberg Businessweek

Rick Wurster, President & CEO of Charles Schwab, discusses Schwab's strategic acquisition of Forge Global, aimed at enhancing client access to private markets. Kevin Gordon analyzes the implications of a potential US government shutdown on labor markets and investor sentiment. Kayla Culver emphasizes the importance of regulatory compliance for advisors in an evolving landscape. Mike Townsend explores how Washington politics influence market dynamics and the need for investors to differentiate between emotional responses and factual risks.

Richard Francis, the President and CEO of Teva Pharmaceuticals, dives into the company's impressive shift toward branded medications, highlighting a notable 33% growth in that sector. He discusses how this strategy, contrasted with a decline in generics, led to a quarterly revenue surprise of $4.48 billion. Richard also covers ongoing pricing negotiations for Austedo and the challenges faced in the active pharmaceutical ingredients sale process, providing insights into Teva's future trajectory in the biopharma landscape.

Rick Wurster, President & CEO of Charles Schwab, reflects on retail investors' role in the market and how Schwab is attracting Gen Z. Lizanne Saunders discusses narrow index gains, the impact of AI on productivity, and the necessity of adaptation for workers. Omar Aguilar emphasizes strong corporate balance sheets and the risks of speculative trading. Kathy Jones analyzes the bond market and hidden risks in private credit, shedding light on the Fed's cautious navigation amidst mixed economic signals.

James Walker, CEO of NANO Nuclear Energy, leads innovative efforts on the KRONOS micro modular reactor, while Will Wade brings his expertise as a Bloomberg News energy reporter. They dive into the challenges and potential of advanced nuclear technology. Key topics include the U.S. nuclear construction landscape, the historical context of reactor closures, and the competitive global nuclear market. They also discuss ambitious timelines for the first small modular reactors and the interplay between immediate energy demands and future nuclear solutions.

Gillian Wolff, a global equity strategist at Bloomberg Intelligence, shares insights on market volatility and the risks of AI-driven rallies. Kathy Wylde, President and CEO of the Partnership for New York City, dives into the forthcoming NYC mayoral election, emphasizing public-private collaboration and fiscal policies. Mark Dixon, founder of IWG, discusses the booming demand for flexible workspaces and trends in global real estate, revealing how companies are adapting to new workplace preferences.

Dr. Christina Smolke, co-founder and CEO of Antheia, is on a mission to transform pharmaceutical production. She discusses the risks of U.S. reliance on foreign active pharmaceutical ingredients and how Antheia's innovative yeast fermentation technology can ensure domestic drug availability. Christina explains the unique process of programming yeast to produce critical medicines and reveals that Antheia has successfully launched its first product. She emphasizes their focus on resolving essential drug shortages and the rigorous safety standards governing their biosynthetic ingredients.

Max Chafkin, a senior reporter at Bloomberg Businessweek, dives into Palantir's remarkable earnings and its role in the AI landscape. Megan Horneman, Chief Investment Officer at Verdence Capital Advisors, analyzes AI-driven market trends and offers keen portfolio strategies amid rising valuations. Adam Goldstein, CEO of Archer Aviation, shares insights on the commercialization of eVTOL technology, upcoming launches, and operational challenges. Together, they unpack the intersections of technology, finance, and innovation shaping the future.

Dr. Fanny Elahi, a physician-scientist and Associate Professor at Mount Sinai, tackles the pressing issue of Alzheimer’s disease, focusing on its higher rates among women. She explains the influence of hormonal changes during menopause and explores the promise of blood biomarkers for early detection. Delving into genetics, she discusses the APOE4 gene and its interaction with hormonal factors. Dr. Elahi also shares her optimism about upcoming breakthroughs in treatments and prevention, highlighting advances in research and FDA approvals.

Mark Mahaney, a leading tech analyst at Evercore ISI, shares insights on Meta's aggressive AI investments and the skepticism surrounding them. Kate Gulliver, CFO of Wayfair, discusses the company's strong Q3 results and innovative AI tools for merchandising. Jimmy Wales, founder of Wikipedia, emphasizes the importance of transparency and community governance in building trust online. Eugene Kang from Archer explores the booming protein snack market and discusses clever distribution strategies to differentiate his brand.

Ellen Wald, an energy policy expert, discusses how potential U.S. strikes on Venezuela might have limited impact on global oil markets due to sanctions. Laura Martin dives into Netflix's strategic moves regarding Warner Bros. and how its stock split could engage more retail investors. Tom Forte provides insights on Amazon's strong AWS performance and discusses its heavy investments in AI. Finally, Dan Sheridan of Brooks Running talks about the running market's growth and how tariffs are shifting their supply chain strategies.